NOVELTY – A culture of Bacillus subtilis LB-262 yielding antimicrobial agent comprises forming of an antibiotic active against gram-positive and gram-negative microorganisms. Also claimed is a process extracting the antimicrobial agent from the cellular culture medium. USE – In biochemistry.
B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.); D16 (Fermentation industry – including fermentation equipment, brewing, yeast production, production of pharmaceuticals and other chemicals by fermentation, microbiology, production of vaccines and antibodies, cell and tissue culture and genetic engineering.)